Iacta Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Iacta Pharmaceuticals?

Iacta Pharmaceuticals has 2 investors including U.S. Department of Defense And InFocus Capital Partners.

Q: How much funding has Iacta Pharmaceuticals raised to date?

Iacta Pharmaceuticals has raised obfuscated.

Overview

Iacta Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Iacta Pharmaceuticals

CB Rank

149241

Iacta Pharma understands that building a pharmaceutical company is more than just science and technology.

Founded

obfuscation

Private

Grant

Irvine, California, United States

1-10

www.iactapharma.com/

Medical

Pharmaceutical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Eric Carter: Chief Medical Officer (CMO)
Yogesh Bahl: CFO

Details

Legal Name

Iacta Pharmaceuticals Inc.

Also Known As

Iacta Pharma

Operating Status

Active

Company Type

For Profit

Founders

Damon Burrows, George Ng, William Pedranti

About the Company

Iacta Pharma understands that building a pharmaceutical company is more than just science and technology. It's about the people behind it. Business partners, scientists, idea generators, and patients and their families.

Phone Number

(844) 422-8279

Contact Email

db@iactapharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

IC 265

A SYK kinase inhibitor developed for the treatment of dry eye disease, aiming to improve safety and efficacy over existing therapies.

IC 800

A dual enkephalinase inhibitor (DENKI) for managing acute ocular pain, particularly post-surgical pain.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Iacta Pharmaceuticals	1	obfuscated obfuscation	U.S. Department of Defense	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Department of Defense	Yes	Grant - Iacta Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Iacta Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Iacta Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Iacta Pharmaceuticals	—
U.S. Department of Defense	Yes	Grant - Iacta Pharmaceuticals	—